VNDA analyst estimates

Vanda Pharmaceuticals (VNDA) analyst ratings, the average price target and its range, and every firm's latest call.

VNDA analyst ratings and price targets

DateFirmCallTarget
Sep 23, 2026OppenheimerVanda Pharmaceuticals initiated with an Outperform at Oppenheimer$10.00
May 11, 2026H.C. WainwrightVanda Pharmaceuticals price target lowered to $21 from $24 at H.C. Wainwright$21.00
Feb 23, 2026H.C. WainwrightVanda Pharmaceuticals price target raised to $24 from $22 at H.C. Wainwright$24.00
Jan 5, 2026H.C. WainwrightVanda Pharmaceuticals price target raised to $22 from $20 at H.C. Wainwright$22.00
Dec 31, 2025JefferiesVanda Pharmaceuticals price target raised to $7.50 from $5 at Jefferies$7.50
Nov 5, 2025B.Riley FinancialB.Riley Starts Vanda Pharmaceuticals (VNDA) at Buy$11.00
Jul 11, 2024Cantor FitzgeraldVanda Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald$11.00